Old	New	Differences
1	1
2	2
3	3	Req. No. 6088 Page 1 1
4	4	2
5	5	3
6	6	4
7	7	5
8	8	6
9	9	7
10	10	8
11	11	9
12	12	10
13	13	11
14	14	12
15	15	13
16	16	14
17	17	15
18	18	16
19	19	17
20	20	18
21	21	19
22	22	20
23	23	21
24	24	22
25	25	23
26	26	24
27	27
28	28	STATE OF OKLAHOMA
29	29
30	30	1st Session of the 59th Legislatu re (2023)
31	31
32	32	HOUSE BILL 2280 By: Echols
33	33
34	34
35	35
36	36
37	37
38	38	AS INTRODUCED
39	39
40	40	An Act relating to public health and safety; amending
41	41	63 O.S. 2021, Section 2-303, which relates to the
42	42	Uniform Controlled Dangerous Subs tances Act;
43	43	increasing registration fee for certain registrants;
44	44	excluding certain regi strants from presumed
45	45	qualification for registration; and declaring an
46	46	emergency.
47	47
48	48
49	49
50	50
51	51
52	52	BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
53	53	SECTION 1. AMENDATORY 63 O.S. 2021, Section 2 -303, is
54	54	amended to read as follows:
55	55	Section 2-303. A. The Director of the Oklahoma State Bureau of
56	56	Narcotics and Dangerous Drugs Control shall register an applicant to
57	57	own a medical facility as describe d in subsection C of Section 2 -302
58	58	of this title, or to manufacture, distribu te, dispense, prescribe,
59	59	administer or use for scientific purposes controlled dangerous
60	60	substances included in Schedules I through V of Section 2 -101 et
61	61	seq. of this title unless the Director determines that the issuance
62	62	of such registration is inconsisten t with the public interest. In
63	63
64	64	Req. No. 6088 Page 2 1
65	65	2
66	66	3
67	67	4
68	68	5
69	69	6
70	70	7
71	71	8
72	72	9
73	73	10
74	74	11
75	75	12
76	76	13
77	77	14
78	78	15
79	79	16
80	80	17
81	81	18
82	82	19
83	83	20
84	84	21
85	85	22
86	86	23
87	87	24
88	88
89	89	determining the public interest, the following factors shall be
90	90	considered:
91	91	1. Maintenance of effective controls against diversion of
92	92	particular controlled dangerous substances and any Schedule I or II
93	93	substance compounded therefrom into other than legitimate medical,
94	94	scientific or industrial channels, including examination of the
95	95	fitness of his or her employees or agents to handle dangerous
96	96	substances;
97	97	2. Compliance with applicable state and local law;
98	98	3. Has been found g uilty of, entered a plea of guilty or nolo
99	99	contendere to a charge under the Uniform Controlled Dangerous
100	100	Substances Act or any other state or federal law relating to any
101	101	substance defined herein as a controlled dangerous substance or any
102	102	felony under the laws of any state or the United States;
103	103	4. Furnishing by the applicant false or fraudulent material
104	104	information in any application filed under Section 2 -101 et seq. of
105	105	this title;
106	106	5. Past experience in the manufacture, distribution,
107	107	dispensing, prescribin g, administering or use for scientific
108	108	purposes of controlled dangerous substances, and the existence in
109	109	the establishment of effective controls against diversion;
110	110	6. Denial, suspension or revocation of the applicant 's federal
111	111	registration to manufacture, distribute or dispense controlled
112	112	dangerous substances as authorized by federal law; and
113	113
114	114	Req. No. 6088 Page 3 1
115	115	2
116	116	3
117	117	4
118	118	5
119	119	6
120	120	7
121	121	8
122	122	9
123	123	10
124	124	11
125	125	12
126	126	13
127	127	14
128	128	15
129	129	16
130	130	17
131	131	18
132	132	19
133	133	20
134	134	21
135	135	22
136	136	23
137	137	24
138	138
139	139	7. Such other factors as may be relevant to and consistent with
140	140	the public health and sa fety.
141	141	Nothing herein shall be deemed to require individual licensed
142	142	pharmacists to register under the provisions of the Uniform
143	143	Controlled Dangerous Substances Act.
144	144	B. Registration granted under subsection A of this section
145	145	shall not entitle a registrant to manufacture, distribute, dispense,
146	146	prescribe, administer or use for scient ific purposes controlled
147	147	dangerous substances in Schedule I or II other than those specified
148	148	in the registration.
149	149	C. Practitioners shall be registered to dispense, prescribe,
150	150	administer or use for scientific purposes substances in Schedules II
151	151	through V if they are authorized to carry on their respective
152	152	activities under the laws of this state. A registration application
153	153	by a practitioner who wishes to conduct research with Sched ule I
154	154	substances shall be accompanied by evidence of the applicant 's
155	155	federal registration to conduct such activity and shall be referred
156	156	to the Medical Research Commission for advice. The Medical Research
157	157	Commission shall promptly advise the Director conc erning the
158	158	qualifications of each practitioner requesting such registration.
159	159	Registration for the purpose of bona fide research or of use for
160	160	scientific purposes with Schedule I substances by a practitioner
161	161	deemed qualified by the Medical Research Commiss ion may be denied
162	162	only on a ground specified in subsection A of Section 2 -304 of this
163	163
164	164	Req. No. 6088 Page 4 1
165	165	2
166	166	3
167	167	4
168	168	5
169	169	6
170	170	7
171	171	8
172	172	9
173	173	10
174	174	11
175	175	12
176	176	13
177	177	14
178	178	15
179	179	16
180	180	17
181	181	18
182	182	19
183	183	20
184	184	21
185	185	22
186	186	23
187	187	24
188	188
189	189	title or if there are reasonable grounds to believe that the
190	190	applicant will abuse or unlawfully transfer such substances or fail
191	191	to safeguard adequately such applicant 's supply of such substances
192	192	against diversion from legitimate medical or scient ific use.
193	193	D. 1. The Director shall initially permit persons to register
194	194	who own or operate any establishment engaged in the manufacture,
195	195	distribution, dispensing, prescribing, a dministering or use for
196	196	scientific purposes of any controlled dangerous subst ances prior to
197	197	June 4, 1991, and who are registered or licensed by the state. Fees
198	198	for registration under this section shall be as follows:
199	199	Practitioners and mid -level
200	200	practitioners $140.00 per year
201	201	of registration
202	202	Home Care Agencies, Hospices &
203	203	Home Care Services $140.00 annually
204	204	Medical Facility Owners $300.00 annually
205	205	Distributors $300.00 annually
206	206	Manufacturers $500.00 $2,500.00 annually
207	207	Manufacturer, Wholesaler, or
208	208	Distributor of drug products
209	209	containing pseudoephedrine
210	210	or phenylpropanolamine $300.00 annually
211	211
212	212	Req. No. 6088 Page 5 1
213	213	2
214	214	3
215	215	4
216	216	5
217	217	6
218	218	7
219	219	8
220	220	9
221	221	10
222	222	11
223	223	12
224	224	13
225	225	14
226	226	15
227	227	16
228	228	17
229	229	18
230	230	19
231	231	20
232	232	21
233	233	22
234	234	23
235	235	24
236	236
237	237	2. A registrant shall be required to pay double the amount of
238	238	the above-listed fee for any renewal of registration received more
239	239	than thirty (30) days late.
240	240	3. A Ten Dollar ($10.00) fee shall be charged for a duplicate
241	241	registration certificate.
242	242	E. Compliance Except for medical marijuana registrants,
243	243	compliance by manufacturers and distributors with the provisions of
244	244	the Federal Controlled Substances Act, 21 U.S.C., Sect ion 801 et
245	245	seq., respecting registration, excluding fees, shall be deemed
246	246	sufficient to qualify for registration under this act.
247	247	SECTION 2. It being immediately necessary for the preservation
248	248	of the public peace, health or safety, an emergency is hereby
249	249	declared to exist, by reason wh ereof this act shall take effect and
250	250	be in full force from and after its passage an d approval.
251	251
252	252	59-1-6088 GRS 12/19/22

Oklahoma 2024 Regular Session

Oklahoma House Bill HB2280 Compare Versions